🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Cochlear clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA and UK registers with Cochlear as lead sponsor. Synced 26 Sep 2026
10Current trials
5Recruiting now
1Drug in these trials
2Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Cochlear is the lead sponsor of 10 current clinical trials in our USA and UK registers. 5 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Dexamethasone. The most-studied condition is Hearing Loss.

ClinicalTrials.gov trials by status

  • Recruiting550%
  • Not yet open220%
  • Active, closed330%

Trials by phase

  • Not applicable990%
  • Observational110%
01

Clinical trials sponsored by Cochlear

10 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array
NCT06936449 · Sensorineural Hearing Loss, Bilateral Hearing Loss
Observational Recruiting 2025-05 USA
Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients
NCT07130136 · ClinicalTrials.gov ↗ · Bone Conduction, Hearing Loss, Conductive, Hearing Loss, Mixed
Not applicable Recruiting 2026-07 UK
An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App
NCT06098482 · ClinicalTrials.gov ↗ · Hearing Loss
Not applicable Recruiting 2024-02 USA
A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults
NCT07287124 · ClinicalTrials.gov ↗ · Hearing Loss, Bilateral Sensorineural
Not applicable Recruiting 2026-04 USA
Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
NCT05318417 · ClinicalTrials.gov ↗ · Hearing Loss, Unilateral, Deafness, Unilateral
Not applicable Recruiting 2022-08 USA
A Study Examining Acceptability of Auditory Implant Fitting Software Technologies
NCT07763873 · Hearing Impairment
Not applicable Not yet open 2026-10 USA
Hearing Outcomes With the Nucleus® 8 Sound Processor and Nucleus® 7 Sound Processor in Adult Veteran and Non-veteran Cochlear Implant Recipients
NCT07582198 · ClinicalTrials.gov ↗ · Hearing Loss
Not applicable Not yet open 2026-05 USA
Speech Performance and Clinic Efficiency With Remote Care Compared With Standard of Care in Adults With a Cochlear Implant in the First 12 Months Post-activation
NCT05552118 · Hearing Loss
Not applicable Active, closed 2024-03 UK
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
NCT06293482 · ClinicalTrials.gov ↗ · Hearing Loss, Sensorineural, Hearing Loss, Bilateral
Not applicable Active, closed 2024-09 USA
Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array
NCT06598059 · ClinicalTrials.gov ↗ · Hearing Loss
Not applicable Active, closed 2025-01 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Cochlear trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Cochlear trials

12 conditions
Hearing Loss4Bone Conduction1Hearing Loss, Conductive1Hearing Loss, Mixed1Sensorineural Hearing Loss1Bilateral Hearing Loss1Hearing Impairment1Hearing Loss, Bilateral Sensorineural1Hearing Loss, Sensorineural1Hearing Loss, Bilateral1Hearing Loss, Unilateral1Deafness, Unilateral1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in USA84
Clinical trials in UK21

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Hearing Loss

SponsorTrials
Oticon Medical2
Sound Pharmaceuticals, Incorporated1
Apple1
Sonova1

Sponsors with the most current trials registered for this condition.

06

Questions about Cochlear trials

How many clinical trials does Cochlear sponsor?

Cochlear is the lead sponsor of 10 current trials on ClinicalTrials.gov in our USA and UK registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Cochlear trials recruiting?

Yes. 5 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Cochlear testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Dexamethasone (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.